• A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates.
An, Yaling, et al. Emerg Microbes Infect 2022 Dec;11: 1058-1071
• Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.
Karmakar, Souvik, et al. J. Infect. Dis. 2014 Jun 15;209(12): 1929-40
• Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses.
Ma, Xiancai, et al. Immunity 2020 12 15;53: 1315-1330.e9
• Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2.
Mooij, Petra, et al. Front Immunol 2022;13: 845887
• Circular RNA vaccines against SARS-CoV-2 and emerging variants.
Qu, Liang, et al. Cell 2022 May 12;185(10): 1728-1744.e16
• T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.
Rollier, C S, et al. Gene Ther. 2016 10;23(10): 753-759
• A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques.
Volkmann, Ariane, et al. Front Immunol 2022;13: 857440